Navigation Links
Thermage, Inc. Announces Distribution Agreement With Eclipse Medical, Ltd.
Date:10/3/2007

HAYWARD, Calif., Oct. 3 /PRNewswire-FirstCall/ -- Thermage, Inc. (Nasdaq: THRM), today announced that it has signed a distribution agreement with Eclipse Medical, Ltd., a leading distributor of advanced aesthetic technology solutions for physician practices. Under the new agreement, Eclipse sales professionals will market the Company's ThermaCool(R) systems and treatment tips in the Southwest region of the United States.

"We are very pleased to have reached this agreement with Eclipse Medical, which represents our first partnership with a distributor in the United States," said Stephen J. Fanning, Chairman, President and Chief Executive Officer, of Thermage. "Eclipse Medical is a significant distributor in the aesthetics market, particularly in the states of Arkansas, Louisiana, Oklahoma and Texas. This relationship will serve to augment our direct sales force with minimal investment and we believe that through our combined efforts we will significantly expand our presence in the Southwest."

"Eclipse Medical continues to seek best in class product offerings for our customers. Thermage solutions clearly meet that description," said Tom O'Brien, CEO, of Eclipse Medical. "We are excited to join forces with Thermage, the true gold standard in non-invasive skin tightening. In our region, combining the efforts of the Eclipse sales force with the Thermage sales force will certainly provide a superior infrastructure for exceeding our customers' expectations."

About Thermage

Thermage's innovative technology provides a unique non-invasive procedure designed to tighten and contour skin, significantly expanding the non-invasive aesthetic applications physicians can offer to the rapidly growing "anti-aging"
'/>"/>

SOURCE Thermage, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. PM announces a new health care order for India
2. Ramdoss Announces Introduction of RCH-II
3. Britain Announces Third Transfusion Related Mad Cow Case
4. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
5. Tibet Announces the Dalai Lama’s Tour of South Americ
6. NHS announces further Cost cutting Measures
7. Indian PM Announces Of Setting Up India Study Center At Tashkent
8. PowderMed Announces Needle-Less Flu Vaccine
9. Malaysia Announces Prison term On People Donating HIV-Contaminated Blood
10. Australian Government Announces Survey To Tackle Childhood Obesity
11. New Zealand Announces 10-year Plan For Betterment Of Mental Health Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2008)... secondary life insurance market ranked 156 among ...merica on Inc. 500 list, BETHESDA, Md., Aug. 20 /...in the secondary life insurance market, announced ...ing insurance related company in the US by,Inc. ma...8 Inc. 500 list of,fastest growing companies in Am...
(Date:8/20/2008)...esidents Gain Access to High Quality Care as State...g. 20 /PRNewswire-USNewswire/ -- Patients who suff...splant will no longer have to,seek that highly spe...p,care outside the borough of the Bronx. Area pati...gh-quality care locally, without having to travel,...
(Date:8/20/2008)...PRINGS, Pa., Aug. 20 /PRNewswire-USNewswire/ -- Go... agricultural industry is struggling,with high fue...ng the need,to secure the state,s energy independe...g adults., Nearly 900 guests gathered to hear the...ay Luncheon at Ag Progress Days, Pennsylvania,s,la...
(Date:8/20/2008)...n of brown globules helps burn calories, hints of ..., Aug. 20 (HealthDay News) -- A protein that induc...good" brown fat that helps burn calories and plays...he Joslin Diabetes Center in Boston. , They sai...ay help lead to new ways to prevent and treat obes...
Breaking Medicine News(10 mins):Health News:Integrity Capital Partners Ranked 2nd Fastest Growing Insurance Related Company in US by Inc. Magazine 2Health News:Liver Transplant Program Established At Montefiore 2Health News:Liver Transplant Program Established At Montefiore 3Health News:Liver Transplant Program Established At Montefiore 4Health News:Pennsylvania Governor Rendell Highlights Renewable Energy, Health Care Reform at Ag Progress Days 2Health News:Bone Growth Protein Also Promotes 'Good' Fat 2
...the Université de Montréal and the Centre hospital...ced an important breakthrough in fighting the// hu...me, scientists have identified a defect in the imm...he flaw. Dr. Rafick-Pierre Sékaly, an eminent rese...
...Medical Sciences (AIIMS) was Friday asked by a cit...untimely demise of a woman suffering// from heart ...sal Commission held the country's most prestigious...ble for gross negligence. The court asked AIIMS t...
...leaders approved the proposed discount drug plan, ...dications and 60% on generic ones for the// low-in...l require the prescription drug companies to enabl...uired to adhere to this by August 2010, failing wh...
...rdered administrations of all 30 districts to coll...the next three days.// The officials were Thursda...hubaneswar, said a senior health department offici...nt to a laboratory in Pune, Maharashtra, as the st...
Other Medicine News:Health News:Researchers Make a Major Strategic Breakthrough in Controlling the AIDS Virus 2
(Date:8/14/2008)... development to begin in late 2008 or in early 200...tCall/ -- Nuvelo, Inc.,(Nasdaq: NUVO ) today anno...concept trial of NU172, demonstrating that the dir...ined anticoagulation with a rapid,return toward ba...afety,profile., "NU172 has the potential to addre...
(Date:8/13/2008)... Fat Intake Improves Insulin Sensitivity and Reduc...ine Responsiveness, PHOENIX, Aug. 13 /PRNewswire-...Kronos Longevity Research Institute (KLRI) found t...nsitivity and reduces inflammatory,markers, but do...was,recently published in Hormones and Metabolic R...
(Date:8/13/2008)...CRP with ISIS 353512 could provide therapeutic ben...mmatory diseases, CARLSBAD, Calif., Aug. 13 /PRNe...asdaq: ISIS ) announced today it has initiated a,...at inhibits the,production of C-reactive protein (...ts with a variety of diseases including cardiovasc...
(Date:8/12/2008)...alif., Aug. 12 /- DURECT Co...e US Food and Drug Administration,(FDA) has accept... granted,Priority Review. The FDA typically grants...potential to demonstrate significant improvements,...mpleting review of a drug,with Priority Review sta...
Breaking Medicine Technology:Nuvelo Announces Positive Phase 1b Proof-of-Concept Data With Anticoagulant NU172 2Nuvelo Announces Positive Phase 1b Proof-of-Concept Data With Anticoagulant NU172 3Nuvelo Announces Positive Phase 1b Proof-of-Concept Data With Anticoagulant NU172 4Study Shows Benefits of a High Omega-3 Diet in Older Adults 2Study Shows Benefits of a High Omega-3 Diet in Older Adults 3Isis Initiates Clinical Trial of CRP Drug 2Isis Initiates Clinical Trial of CRP Drug 3REMOXY(R) NDA Filing Accepted by FDA and Priority Review Granted 2REMOXY(R) NDA Filing Accepted by FDA and Priority Review Granted 3Capital BlueCross Receives Prestigious Brand Excellence Award From The Blue Cross 26 Blue Shield Association 14353 1Capital BlueCross Receives Prestigious Brand Excellence Award From The Blue Cross 26 Blue Shield Association 14353 2Angiotech showcases its Hemostream 28TM 29 Dialysis Catheter at the Society of Interventional Radiology 28SIR 29 Annual Meeting 3952 1Angiotech showcases its Hemostream 28TM 29 Dialysis Catheter at the Society of Interventional Radiology 28SIR 29 Annual Meeting 3952 2Angiotech showcases its Hemostream 28TM 29 Dialysis Catheter at the Society of Interventional Radiology 28SIR 29 Annual Meeting 3952 3Angiotech showcases its Hemostream 28TM 29 Dialysis Catheter at the Society of Interventional Radiology 28SIR 29 Annual Meeting 3952 4Angiotech showcases its Hemostream 28TM 29 Dialysis Catheter at the Society of Interventional Radiology 28SIR 29 Annual Meeting 3952 5Dialysis Corporation of America Reports Fourth Quarter and Year Ended December 31 2007 Results 14347 1Dialysis Corporation of America Reports Fourth Quarter and Year Ended December 31 2007 Results 14347 2Dialysis Corporation of America Reports Fourth Quarter and Year Ended December 31 2007 Results 14347 3Dialysis Corporation of America Reports Fourth Quarter and Year Ended December 31 2007 Results 14347 4Dialysis Corporation of America Reports Fourth Quarter and Year Ended December 31 2007 Results 14347 5Dialysis Corporation of America Reports Fourth Quarter and Year Ended December 31 2007 Results 14347 6Dialysis Corporation of America Reports Fourth Quarter and Year Ended December 31 2007 Results 14347 7Trubion Pharmaceuticals Inc Reports Fourth Quarter and Year Ended 2007 Financial Results and Provides 2008 Financial Outlook 3950 1Trubion Pharmaceuticals Inc Reports Fourth Quarter and Year Ended 2007 Financial Results and Provides 2008 Financial Outlook 3950 2Trubion Pharmaceuticals Inc Reports Fourth Quarter and Year Ended 2007 Financial Results and Provides 2008 Financial Outlook 3950 3Trubion Pharmaceuticals Inc Reports Fourth Quarter and Year Ended 2007 Financial Results and Provides 2008 Financial Outlook 3950 4Trubion Pharmaceuticals Inc Reports Fourth Quarter and Year Ended 2007 Financial Results and Provides 2008 Financial Outlook 3950 5Trubion Pharmaceuticals Inc Reports Fourth Quarter and Year Ended 2007 Financial Results and Provides 2008 Financial Outlook 3950 6
...ALEIGH, N.C., April 18, 2007 /PRNewswire/ -- Micel...ll be presenting,data on use of its supercritical ...ug-eluting stents at the upcoming Society for,Biom...Chicago,Illinois. , The abstracts describe use of... e-RESS technology to create drug-eluting stents,c...
...ta Reported at American Association for Cancer Res...RNewswire-FirstCall/ -- Favrille,Inc. , a biophar...tive immunotherapies for the treatment of cancer, ...d activity from insect-cell,derived idiotype (Id) ...immunotherapy product candidate FavId(R) for B-cel...
Other Medicine Technology:Micell Technologies Presents Data on Novel Drug-Eluting Stents 2Micell Technologies Presents Data on Novel Drug-Eluting Stents 3Favrille Announces Results From Study Showing Enhanced Activity,From Insect Cell-Derived Immunotherapy for Lymphoma 2Favrille Announces Results From Study Showing Enhanced Activity,From Insect Cell-Derived Immunotherapy for Lymphoma 3Favrille Announces Results From Study Showing Enhanced Activity,From Insect Cell-Derived Immunotherapy for Lymphoma 4
Unit System Slide Cabinet is constructed from hardwood for long lasting.
Shandon Slide File Storage System
Shandon Microscope Slide Trays
... luminance white LED (Light Emitting Diode) light ..., to give you the freedom of using a slit lamp any...t 1.5 lbs. (0.68 kg) with its battery and fits eas...portable design and convenient carrying case make ...
Medicine Products: